Therapeutic effects of curcumin in inflammatory and immune-mediated diseases: A nature-made jack-of-all-trades?

Journal of Cellular Physiology

Volumn 233, Issue 2, 2018, Pages 830-848

  Abdollahi, Elham ^a,b   Momtazi, Amir Abbas ^c   Johnston, Thomas P ^d   Sahebkar, Amirhossein ^b,e  

^a MASHHAD UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b MASHHAD UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c MASHHAD UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d UNIVERSITY OF MISSOURI KANSAS CITY   (United States)

^e MASHHAD UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

autoimmune disease; curcumin; immune system; inflammation

Indexed keywords

CURCUMIN; CYTOKINE; AUTACOID; IMMUNOLOGIC FACTOR;

ALLERGIC DISEASE; ALLERGIC ENCEPHALOMYELITIS; ANTINEOPLASTIC ACTIVITY; B LYMPHOCYTE; BRAIN HEMORRHAGE; CANCER IMMUNOTHERAPY; CHRONIC LUNG DISEASE; CYTOKINE PRODUCTION; DENDRITIC CELL; DRUG EFFICACY; DRUG MECHANISM; DRUG TARGETING; GRAFT REJECTION; GRAFT VERSUS HOST REACTION; HUMAN; IMMUNE MEDIATED INJURY; IMMUNOMODULATION; IMMUNOPATHOLOGY; IMMUNOPHARMACOLOGY; INFLAMMATION; INFLAMMATORY BOWEL DISEASE; INFLAMMATORY DISEASE; INSULIN DEPENDENT DIABETES MELLITUS; LIVER INJURY; MACROPHAGE; MEDIATOR RELEASE; MULTIPLE SCLEROSIS; NATURAL KILLER CELL; NEUTROPHIL; NONHUMAN; OBESITY; OSTEOARTHRITIS; PANCREATITIS; PERIODONTAL DISEASE; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; RHEUMATOID ARTHRITIS; SERUM SICKNESS; SJOEGREN SYNDROME; SYSTEMIC LUPUS ERYTHEMATOSUS; T LYMPHOCYTE SUBPOPULATION; THERAPY EFFECT; TUMOR IMMUNITY; ANIMAL; DRUG EFFECTS; IMMUNOLOGY; METABOLISM; SIGNAL TRANSDUCTION;

ANIMALS; CURCUMIN; HUMANS; IMMUNE SYSTEM DISEASES; IMMUNOLOGIC FACTORS; INFLAMMATION; INFLAMMATION MEDIATORS; SIGNAL TRANSDUCTION;

EID: 85012276107     PISSN: 00219541     EISSN: 10974652     Source Type: Journal    
DOI: 10.1002/jcp.25778     Document Type: Review

References (189)

1. Abdollahi, E., Tavasolian, F., Ghasemi, N., Mirghanizadeh, S. A., Azizi, M., Ghoryani, M., & Samadi, M. (2015). Association between lower frequency of R381Q variant (rs11209026) in IL-23 receptor gene and increased risk of recurrent spontaneous abortion (RSA). Journal of Immunotoxicology, 12(4), 317–321.
2. Abdollahi, E., Tavasolian, F., Momtazi-Borojeni, A. A., Samadi, M., & Rafatpanah, H. (2016). Protective role of R381Q (rs11209026) polymorphism in IL-23R gene in immune-mediated diseases: A comprehensive review. Journal of Immunotoxicology, 13(3), 286–300.
3. Abe, Y., Hashimoto, S., & HORIE, T. (1999). Curcumin inhibition of inflammatory cytokine production by human peripheral blood monocytes and alveolar macrophages. Pharmacological Research, 39(1), 41–47.
4. Aggarwal, B. B., Kumar, A., & Bharti, A. C. (2003). Anticancer potential of curcumin: preclinical and clinical studies. Anticancer Research, 23(1A), 363–398.
5. Ahmed, A. M., El Fouhil, A. F., Mohamed, R. A., Atteya, M., Abdel-Baky, N. A., AlRoalle A. H., & Aldahmash, A. M. (2015). Curcumin ameliorates experimental autoimmune acute myocarditis in rats as evidenced by decrease in thioredoxin immunoreactivity. Folia Morphologica (Poland), 74(3), 318–324.
6. Ali, R., Nicholas, R. S. J., & Muraro, P. A. (2013). Drugs in development for relapsing multiple sclerosis. Drugs, 73(7), 625–650.
7. Antony, S., Kuttan, R., & Kuttan, G. (1999). Immunomodulatory activity of curcumin. Immunological Investigations, 28(5–6), 291–303.
8. Bachmeier, B. E., Mohrenz, IV, Mirisola, V., Schleicher, E., Romeo, F., Höhneke, C., … Pfeffer, U. (2008). Curcumin downregulates the inflammatory cytokines CXCL1 and-2 in breast cancer cells via NFκB. Carcinogenesis, 29(4), 779–789.
9. Bai, X., Oberley-Deegan, R. E., Bai, A., Ovrutsky, A. R., Kinney, W. H., Weaver, M., … Chan, E. D. (2016). Curcumin enhances human macrophage control of Mycobacterium tuberculosis infection. Respirology, 21(5), 951–957.
10. Bakır, B., Yetkin Ay, Z., Büyükbayram, H. İ., Kumbul Doğuç, D., Bayram, D., Candan, İ. A., & Uskun, E. (2016). Effect of curcumin on systemic T helper 17 cell response; gingival expressions of interleukin-17 and retinoic acid receptor-Related orphan receptor γt; and alveolar bone loss in experimental periodontitis. Journal of Periodontology, 87(11), e183–e191.
11. Banerjee, M., Tripathi, L., Srivastava, V., Puri A., & Shukla, R. (2003). Modulation of inflammatory mediators by ibuprofen and curcumin treatment during chronic inflammation in rat. Immunopharmacology and Immunotoxicology, 25(2), 213–224.
12. Berer, A., Stöckl, J., Majdic, O., Wagner, T., Kollars, M., Lechner, K., … Oehler, L. (2000). 1, 25-Dihydroxyvitamin D 3 inhibits dendritic cell differentiation and maturation in vitro. Experimental Hematology, 28(5), 575–583.
13. Bereswill, S., Muñoz, M., Fischer, A., Plickert, R., Haag, L.-M., Otto, B., … Heimesaat, M. M. (2010). Anti-inflammatory effects of resveratrol, curcumin and simvastatin in acute small intestinal inflammation. PLoS ONE, 5(12), e15099.
14. Bharti, A. C., Donato, N., Singh, S., Aggarwal, B. B. (2003). Curcumin (diferuloylmethane) down-regulates the constitutive activation of nuclear factor–κB and IκBα kinase in human multiple myeloma cells, leading to suppression of proliferation and induction of apoptosis. Blood, 101(3), 1053–1062.
15. Bharti, A. C., Panigrahi, A., Sharma, P. K., Gupta, N., Kumar, R., Shukla, S., … Mehra, N. K. (2010). Clinical relevance of curcumin-induced immunosuppression in living-related donor renal transplant: An in vitro analysis. Experimental and Clinical Transplantation, 8(2), 161–171.
16. Bhattacharyya, S., Hossain, D. M. S., Mohanty, S., Sen, G. S., Chattopadhyay, S., Banerjee, S., … Das, T. (2010). Curcumin reverses T cell-mediated adaptive immune dysfunctions in tumor-bearing hosts. Cellular & Molecular Immunology, 7(4), 306–315.
17. Bhaumik, S., Jyothi, M. D., & Khar, A. (2000). Differential modulation of nitric oxide production by curcumin in host macrophages and NK cells. FEBS Letters, 483(1), 78–82.
18. Bill, M. A., Bakan, C., Benson, D. M., Fuchs, J., Young, G., & Lesinski, G. B. (2009). Curcumin induces proapoptotic effects against human melanoma cells and modulates the cellular response to immunotherapeutic cytokines. Molecular Cancer Therapeutics, 8(9), 2726–2735.
19. Billerey-Larmonier, C., Uno, J. K., Larmonier, N., Midura, A. J., Timmermann B., Ghishan, F. K., & Kiela, P. R. (2008). Protective effects of dietary curcumin in mouse model of chemically induced colitis are strain dependent. Inflammatory Bowel Diseases, 14(6), 780–793.
20. Biswas, S. K., McClure, D., Jimenez, L. A., Megson, I. L., & Rahman, I. (2005). Curcumin induces glutathione biosynthesis and inhibits NF-κB activation and interleukin-8 release in alveolar epithelial cells: Mechanism of free radical scavenging activity. Antioxidants & Redox Signaling, 7(1–2), 32–41.
21. Bonham, C. A., Lu, L., Banas, R. A., Fontes, P., Rao, A. S., Starzl, T. E., … Thomson, A. W. (1996). TGF-β1 pretreatment impairs the allostimulatory function of human bone marrow-derived antigen-presenting cells for both naive and primed T cells. Transplant Immunology, 4(3), 186–191.
22. Brouet, I., & Ohshima, H. (1995). Curcumin, an anti-tumor promoter and anti-inflammatory agent, inhibits induction of nitric oxide synthase in activated macrophages. Biochemical and Biophysical Research Communications, 206(2), 533–540.
23. Brownlee, M. (1994). Glycation and diabetic complications. Diabetes, 43(6), 836–842.
24. Buhrmann, C., Mobasheri, A., Busch, F., Aldinger, C., Stahlmann, R., Montaseri, A., & Shakibaei, M. (2011). Curcumin modulates nuclear factor κB (NF-κB)-mediated Inflammation in human tenocytes in vitro role of the phosphatidylinositol 3-kinase/akt pathway. Journal of Biological Chemistry, 286(32), 28556–28566.
25. Bush, J. A., Cheung, K.-J. J., & Li, G. (2001). Curcumin induces apoptosis in human melanoma cells through a Fas receptor/caspase-8 pathway independent of p53. Experimental Cell Research, 271(2), 305–314.
26. Camacho-Barquero, L., Villegas, I., Sánchez-Calvo, J. M., Talero, E., Sánchez-Fidalgo, S., Motilva, V., & de la Lastra, C. A. (2007). Curcumin, a Curcuma longa constituent, acts on MAPK p38 pathway modulating COX-2 and iNOS expression in chronic experimental colitis. International Immunopharmacology, 7(3), 333–342.
27. Carroll, M. C. (2004). The complement system in regulation of adaptive immunity. Nature Immunology, 5(10), 981–986.
28. Castro, C., Barcala Tabarrozzi, A., Winnewisser, J., Gimeno, M., Antunica Noguerol, M., Liberman, A., … Perone, M. (2014). Curcumin ameliorates autoimmune diabetes. Evidence in accelerated murine models of type 1 diabetes. Clinical & Experimental Immunology, 177(1), 149–160.
29. Caux, C., Massacrier, C., Vanbervliet, B., Barthelemy, C., Liu, Y.-J., & Banchereau, J. (1994). Interleukin 10 inhibits T cell alloreaction induced by human dendritic cells. International Immunology, 6(8), 1177–1185.
30. Chan, M. M.-Y., Huang, H.-I., Fenton, M. R., & Fong, D. (1998). In vivo inhibition of nitric oxide synthase gene expression by curcumin, a cancer preventive natural product with anti-inflammatory properties. Biochemical Pharmacology, 55(12), 1955–1962.
31. Cho, J.-W., Lee, K.-S., & Kim, C.-W. (2007). Curcumin attenuates the expression of IL-1ß, IL-6, and TNF-α as well as cyclin E in TNF-α-treated HaCaT cells: NF-κB and MAPKs as potential upstream targets. International Journal Molecular Medicine, 19, 469–474.
32. Choi, I., Kang, H. S., Yang, Y., & Pyun, K. H. (1994). IL-6 induces hepatic inflammation and collagen synthesis in vivo. Clinical & Experimental Immunology, 95(3), 530–535.
33. Chong, L., Zhang, W., Nie, Y., Yu, G., Liu, L., Lin, L., … Li, C. (2014). Protective effect of curcumin on acute airway inflammation of allergic asthma in mice through Notch1-GATA3 signaling pathway. Inflammation, 37(5), 1476–1485.
34. Choudhuri, T., Pal, S., Agwarwal, M. L., Das, T., & Sa, G. (2002). Curcumin induces apoptosis in human breast cancer cells through p53-dependent Bax induction. FEBS Letters, 512(1–3), 334–340.
35. Choy, E. H., & Panayi, G. S. (2001). Cytokine pathways and joint inflammation in rheumatoid arthritis. New England Journal of Medicine, 344(12), 907–916.
36. Chueh, S. C. J., Lai, M. K., Liu, I. S., Teng, F. C., & Chen, J. (2003). Curcumin enhances the immunosuppressive activity of cyclosporine in rat cardiac allografts and in mixed lymphocyte reactions. Transplantation Proceedings, 35(4), 1603–1605.
37. Chung, S.-H., Choi, S. H., Choi, J. A., Chuck, R. S., & Joo, C.-K. (2012). Curcumin suppresses ovalbumin-induced allergic conjunctivitis. Molecular Vision, 18: 1966–1972.
38. Clutterbuck, A. L., Mobasheri, A., Shakibaei, M., Allaway, D., & Harris, P. (2009). Interleukin-1β-Induced extracellular matrix degradation and glycosaminoglycan release is inhibited by curcumin in an explant model of cartilage inflammation. Annals of the New York Academy of Sciences, 1171(1), 428–435.
39. Cosmi, L., Liotta, F., Maggi, E., Romagnani, S., & Annunziato, F. (2011). Th17 cells: New players in asthma pathogenesis. Allergy, 66(8), 989–998.
40. Csaki, C., Mobasheri, A., & Shakibaei, M. (2009). Synergistic chondroprotective effects of curcumin and resveratrol in human articular chondrocytes: Inhibition of IL-1β-induced NF-κB-mediated inflammation and apoptosis. Arthritis Research & Therapy, 11(6), 1.
41. Cundell, D. R., & Wilkinson, F. (2014). Curcumin: Powerful immunomodulator from turmeric. Current Immunology Reviews, 10(2), 122–132.
42. Dasu, M. R., Devaraj, S., Zhao, L., Hwang, D. H., & Jialal, I. (2008). High glucose induces toll-like receptor expression in human monocytes Mechanism of activation. Diabetes, 57(11), 3090–3098.
43. Davis, J. M., Murphy, E. A., Carmichael, M. D., Zielinski, M. R., Groschwitz, C. M., Brown, A. S., … Mayer, E. P. (2007). Curcumin effects on inflammation and performance recovery following eccentric exercise-induced muscle damage. American Journal of Physiology-Regulatory, Integrative and Comparative Physiology, 292(6), R2168–R2173.
44. De Smedt, T., Van Mechelen, M., De Becker, G., Urbain, J., Leo, O., & Moser, M. (1997). Effect of interleukin-10 on dendritic cell maturation and function. European Journal of Immunology, 27(5), 1229–1235.
45. Decoté-Ricardo, D., Chagas, K., Rocha, J., Redner, P., Lopes, U., Cambier, J., … Peçanha, L. (2009). Modulation of in vitro murine B-lymphocyte response by curcumin. Phytomedicine, 16(10), 982–988.
46. Deters, M., Hütten, H., & Kaever, V. (2013). Synergistic immunosuppressive effects of the mTOR inhibitor sirolimus and the phytochemical curcumin. Phytomedicine, 20(2), 120–123.
47. Effros, R. M., & Nagaraj, H. (2007). Asthma: New developments concerning immune mechanisms, diagnosis and treatment. Current Opinion in Pulmonary Medicine, 13(1), 37–43.
48. Ellison, C. A., Natuik, S. A., Fischer, J. M., & Gartner, J. G. (2004). Protective effect of curcumin in an F1-Hybrid model of acute graft-vs. -Host disease. Blood, 104(11), 4978–4978.
49. Fahey, A. J., Adrian Robins, R., & Constantinescu, C. S. (2007). Curcumin modulation of IFN-β and IL-12 signalling and cytokine induction in human T cells. Journal of Cellular and Molecular Medicine, 11(5), 1129–1137.
50. Fantini, M. C., & Pallone, F. (2008). Cytokines: From gut inflammation to colorectal cancer. Current Drug Targets, 9(5), 375–380.
51. Fiala, M. (2015). Curcumin and omega-3 fatty acids enhance NK cell-induced apoptosis of pancreatic cancer cells but curcumin inhibits interferon-γ production: Benefits of omega-3 with curcumin against cancer. Molecules, 20(2), 3020–3026.
52. Fontenot, J. D., Gavin, M. A., & Rudensky, A. Y. (2003). Foxp3 programs the development and function of CD4+ CD25+ regulatory T cells. Nature Immunology, 4(4), 330–336.
53. Fu, Y., Zheng, S., Lin, J., Ryerse, J., & Chen, A. (2008). Curcumin protects the rat liver from CCl4-caused injury and fibrogenesis by attenuating oxidative stress and suppressing inflammation. Molecular Pharmacology, 73(2), 399–409.
54. Funk, J. L., Frye, J. B., Oyarzo, J. N., Kuscuoglu, N., Wilson, J., McCaffrey, G., … Jolad, S. D. (2006). Efficacy and mechanism of action of turmeric supplements in the treatment of experimental arthritis. Arthritis & Rheumatism, 54(11), 3452–3464.
55. Ganjali, S., Sahebkar, A., Mahdipour, E., Jamialahmadi, K., Torabi, S., Akhlaghi, S., … Ghayour-Mobarhan, M. (2014). Investigation of the effects of curcumin on serum cytokines in obese individuals: A randomized controlled trial. Scientific World Journal, 2014, 898361.
56. Gao, X., Kuo, J., Jiang, H., Deeb, D., Liu, Y., Divine, G., … Gautam, S. C. (2004). Immunomodulatory activity of curcumin: Suppression of lymphocyte proliferation, development of cell-mediated cytotoxicity, and cytokine production in vitro. Biochemical Pharmacology, 68(1), 51–61.
57. Ghandadi, M., & Sahebkar, A. (2016). Curcumin: An effective inhibitor of interleukin-6. Current Pharmaceutical Design. doi: 10.2174/1381612822666161006151605
58. Gold, R., Hartung, H.-P., & Toyka, K. V. (2000). Animal models for autoimmune demyelinating disorders of the nervous system. Molecular Medicine Today, 6(2), 88–91.
59. Golombick, T., Diamond, T. H, Manoharan, A., & Ramakrishna, R. (2015). The effect of curcumin (as Meriva) on absolute lymphocyte count (ALC), NK cells and T cell populations in patients with stage 0/1 chronic lymphocytic leukemia. Journal of Cancer Therapy, 6(07), 566.
60. Gonzales, A. M., & Orlando, R. A. (2008). Curcumin and resveratrol inhibit nuclear factor-kappaB-mediated cytokine expression in adipocytes. Nutrition & Metabolism, 5(1), 1.
61. Grandjean-Laquerriere, A., Gangloff, S. C., Le Naour, R., Trentesaux, C., Hornebeck, W., & Guenounou, M. (2002). Relative contribution of NF-κB and AP-1 in the modulation by curcumin and pyrrolidine dithiocarbamate of the UVB-induced cytokine expression by keratinocytes. Cytokine, 18(3), 168–177.
62. Guimarães, M. R., Coimbra, L. S., de Aquino, S. G., Spolidorio, L. C., Kirkwood, K. L., & Rossa, C. (2011). Potent anti-inflammatory effects of systemically administered curcumin modulate periodontal disease in vivo. Journal of Periodontal Research, 46(2), 269–279.
63. Guimarães, M. R., de Aquino, S. G., Coimbra, L. S., Spolidorio, L. C., Kirkwood, K. L., & Rossa, C. (2012). Curcumin modulates the immune response associated with LPS-induced periodontal disease in rats. Innate Immunity, 18(1), 155–163.
64. Gulcubuk, A., Altunatmaz, K., Sonmez, K., Haktanir-Yatkin, D., Uzun, H., Gurel, A., & Aydin, S. (2006). Effects of curcumin on tumour necrosis factor-α and interleukin-6 in the late phase of experimental acute pancreatitis. Journal of Veterinary Medicine Series A, 53(1), 49–54.
65. Guo, X.-J., Zhou, M., Ren, L.-P., Yang, M., Huang, S.-G., & Xu, W.-G. (2009). Small interfering RNA-mediated knockdown of Notch1 in lung. Chinese Medical Journal, 122(21), 2647–2651.
66. Hackstein, H., Morelli, A. E., Larregina, A. T., Ganster, R. W., Papworth, G. D., Logar, A. J., … Thomson, A. W. (2001). Aspirin inhibits in vitro maturation and in vivo immunostimulatory function of murine myeloid dendritic cells. The Journal of Immunology, 166(12), 7053–7062.
67. Han, S.-S., Keum, Y.-S., Seo, H.-J., & Surh, Y.-J. (2002). Curcumin suppresses activation of NF-κB and AP-1 induced by phorbol ester in cultured human promyelocytic leukemia cells. BMB Reports, 35(3), 337–342.
68. Haque, S., Lee, H., Waqas, B., Chiorazzi, N., & Mongini P. (2010). Anti-inflammatory curcumin inhibits AID expression within cycling human B cells (96. 21). The Journal of Immunology, 184(1 Supplement), 96.21–96.21.
69. Hatcher, H., Planalp, R., Cho, J., Torti, F., & Torti, S. (2008). Curcumin: From ancient medicine to current clinical trials. Cellular and Molecular Life Sciences, 65(11), 1631–1652.
70. Huang, G., Yang, Y., Xu, Z., Zhou, P., Gong, W., Li, Y., … He, F. (2011). Downregulation of B lymphocyte stimulator expression by curcumin in B lymphocyte via suppressing nuclear translocation of NF-κB. European Journal of Pharmacology, 650(1), 451–457.
71. Huang, S., Zhao, L., Kim, K., Lee, D. S., & Hwang, D. H. (2008). Inhibition of Nod2 signaling and target gene expression by curcumin. Molecular Pharmacology, 74(1), 274–281.
72. Huang, S., Zhao, L., Kim, K., Lee, D. S., & Hwang, D. (2009). Inhibition of NOD2 signaling and target gene expression by curcumin. The FASEB Journal, 23(1 Supplement), 717.19–717.19.
73. Hyodo, N., Tajimi, M., Ugajin, T., Nakamura, I., & Imawari, M. (2003). Frequencies of interferon-γ and interleukin-10 secreting cells in peripheral blood mononuclear cells and liver infiltrating lymphocytes in chronic hepatitis B virus infection. Hepatology Research, 27(2), 109–116.
74. Jacob, A., Chaves, L., Eadon, M. T., Chang, A., Quigg, R. J., & Alexander, J. J. (2013). Curcumin alleviates immune-complex-mediated glomerulonephritis in factor-H-deficient mice. Immunology, 139(3), 328–337.
75. Jagetia, G. C., & Aggarwal, B. B. (2007). “ Spicing up” of the immune system by curcumin. Journal of Clinical Immunology, 27(1), 19–35.
76. Jain, S. K., Rains, J., Croad, J., Larson, B., & Jones, K. (2009). Curcumin supplementation lowers TNF-α, IL-6, IL-8, and MCP-1 secretion in high glucose-treated cultured monocytes and blood levels of TNF-α, IL-6, MCP-1, glucose, and glycosylated hemoglobin in diabetic rats. Antioxidants & Redox Signaling, 11(2), 241–249.
77. Jian, Y., Wang, J., Mai, G., Zhang, Y., & Lai, Z. (2004). [Modulation of intestinal mucosal inflammatory factors by curcumin in rats with colitis]. Academic Journal of the First Medical College of PLA, 24(12), 1353–1358.
78. Jiang, H., Deng, C.-S., Zhang, M., & Xia, J. (2006). Curcumin-attenuated trinitrobenzene sulphonic acid induces chronic colitis by inhibiting expression of cyclooxygenase-2. World Journal of Gastroenterology, 12(24), 3848.
79. Jiang, C. X., Wu, L., Wu, J., Yu, Z. M., & Li, X. K. (2016). Curcumin analog exhibited anti-inflammatory activity through inhibiting ERK/JNK and NF-κB signaling pathway. Chinese Traditional and Herbal Drugs, 47(16), 2871–2876.
80. Jobin, C., Bradham, C. A., Russo, M. P., Juma, B., Narula, A. S., Brenner, D. A., & Sartor, R. B. (1999). Curcumin blocks cytokine-mediated NF-κB activation and proinflammatory gene expression by inhibiting inhibitory factor I-κB kinase activity. The Journal of Immunology, 163(6), 3474–3483.
81. Julie, S., & Jurenka, M. (2009). Anti-inflammatory properties of curcumin, a major constituent. Alternative Medicine Review, 14(2), 142–153.
82. Jung, I. D., Jeong, Y.-I., Lee, C.-M., Noh, K. T., Jeong, S. K., Chun, S. H., … Shin, Y. K. (2010). COX-2 and PGE2 signaling is essential for the regulation of IDO expression by curcumin in murine bone marrow-derived dendritic cells. International Immunopharmacology, 10(7), 760–768.
83. Jurrmann, N., Brigelius-Flohé, R., & Böl, G.-F. (2005). Curcumin blocks interleukin-1 (IL-1) signaling by inhibiting the recruitment of the IL-1 receptor-Associated kinase IRAK in murine thymoma EL-4 cells. The Journal of Nutrition, 135(8), 1859–1864.
84. Kanakasabai, S., Casalini, E., Walline, C. C., Mo, C., Chearwae, W., & Bright, J. J. (2012). Differential regulation of CD4+ T helper cell responses by curcumin in experimental autoimmune encephalomyelitis. The Journal of Nutritional Biochemistry, 23(11), 1498–1507.
85. Kang, B. Y., Chung, S. W., Chung, W.-J., Im, S.-Y., Hwang, S. Y., & Kim, T. S. (1999). Inhibition of interleukin-12 production in lipopolysaccharide-activated macrophages by curcumin. European Journal of Pharmacology, 384(2), 191–195.
86. Kang, B., Song, Y., Kim, K. M., Choe, Y., Hwang, S., & Kim, T. S. (1999). Curcumin inhibits Th1 cytokine profile in CD4+ T cells by suppressing interleukin-12 production in macrophages. British Journal of Pharmacology, 128(2), 380–384.
87. Karimian, M. S., Pirro, M., Majeed, M., & Sahebkar, A. (2016). Curcumin as a natural regulator of monocyte chemoattractant protein-1. Cytokine Growth Factor Rev. doi: 10.1016/j.cytogfr.2016.10.001
88. Kim, G.-Y., Kim, K.-H., Lee, S.-H., Yoon, M.-S., Lee, H.-J., Moon, D.-O., … Park, Y.-M. (2005). Curcumin inhibits immunostimulatory function of dendritic cells: MAPKs and translocation of NF-κB as potential targets. The Journal of Immunology, 174(12), 8116–8124.
89. Kim, W., Fan, Y.-Y., Smith, R., Patil, B., Jayaprakasha, G. K., McMurray, D. N., & Chapkin, R. S. (2009). Dietary curcumin and limonin suppress CD4+ T-cell proliferation and interleukin-2 production in mice. The Journal of Nutrition, 139(5), 1042–1048.
90. Kloesch, B., Becker, T., Dietersdorfer, E., Kiener, H., & Steiner, G. (2013). Anti-inflammatory and apoptotic effects of the polyphenol curcumin on human fibroblast-like synoviocytes. International Immunopharmacology, 15(2), 400–405.
91. Kobayashi, T., Hashimoto, S., & Horie, T. (1997). Curcumin inhibition of Dermatophagoides farinea-induced interleukin-5 (IL-5) and granulocyte macrophage-colony stimulating factor (GM-CSF) production by lymphocytes from bronchial asthmatics. Biochemical Pharmacology, 54(7), 819–824.
92. Krivosikova, M., Dallos, T., Maslinski, W., & Buc, M. (2008). B cell activating factor, its role in autoimmunity, and targeting in autoimmune diseases. Bratislavske Lekarske Listy, 110(3), 137–145.
93. Kulkarni, A. P., Ghebremariam, Y. T., & Kotwal, G. J. (2005). Curcumin inhibits the classical and the alternate pathways of complement activation. Annals of the New York Academy of Sciences, 1056(1), 100–112.
94. Kurien, B. T., D'Souza, A., & Scofield, R. H. (2010). Heat-solubilized curry spice curcumin inhibits antibody-antigen interaction in in vitro studies: A possible therapy to alleviate autoimmune disorders. Molecular Nutrition & Food Research, 54(8), 1202–1209.
95. Kurup, V. P., & Barrios, C. S. (2008). Immunomodulatory effects of curcumin in allergy. Molecular Nutrition & Food Research, 52(9), 1031–1039.
96. Kurup, V. P., Barrios, C. S., Raju, R., Johnson, B. D., Levy, M. B., & Fink, J. N. (2007). Immune response modulation by curcumin in a latex allergy model. Clinical and Molecular Allergy, 5(1), 1.
97. Larmonier, C. B., Midura-Kiela, M., Ramalingam, R., Laubitz, D., Janikashvili, N., Larmonier, N., … Kiela P. R. (2011). Modulation of neutrophil motility by curcumin: Implications for inflammatory bowel disease. Inflammatory Bowel Diseases, 17(2), 503–515.
98. Lee, J.-I., Ganster, R. W., Geller, D. A., Burckart, G. J., Thomson, A. W., & Lu, L. (1999). Cyclosporine A inhibits the expression of costimulatory molecules on in vitro-generated dendritic cells: Association with reduced nuclear translocation of nuclear factor kappa B1. Transplantation, 68(9), 1255–1263.
99. Lee, H., Kim, H., Lee, G., Chung, H.-S., & Bae, H. (2013). Curcumin attenuates lupus nephritis upon interaction with regulatory T cells in New Zealand Black/White mice. British Journal of Nutrition, 110(01), 69–76.
100. Lelli, D., Sahebkar, A., Johnston, T. P., & Pedone, C. (2016). Curcumin use in pulmonary diseases: State of the art and future perspectives. Pharmacol Research, 115, 133–148.
101. Li, X., Lu, Y., Jin, Y., Son, J. K., Lee, S. H., & Chang, H. W. (2014). Curcumin inhibits the activation of immunoglobulin e-mediated mast cells and passive systemic anaphylaxis in mice by reducing serum eicosanoid and histamine levels. Biomolecules and Therapeutics, 22(1), 27–34.
102. Lian, Y. T., Yang, X. F., Wang, Z. H., Yang, Y., Yang, Y., Shu, Y. W., … Liu, K. (2013). Curcumin serves as a human Kv1. 3 blocker to inhibit effector memory T lymphocyte activities. Phytotherapy Research, 27(9), 1321–1327.
103. Literat, A., Su, F., Norwicki, M., Durand, M., Ramanathan, R., Jones, C., … Kwong, K. (2001). Regulation of pro-inflammatory cytokine expression by curcumin in hyaline membrane disease (HMD). Life Sciences, 70(3), 253–267.
104. Liu, W., Yuan, J., Zhu, H., Zhang, X., Li, L., Liao, X., … Lin, J. (2016). Curcumin reduces brain-infiltrating T lymphocytes after intracerebral hemorrhage in mice. Neuroscience Letters, 620, 74–82.
105. Lloyd, C. M., & Hessel, E. M. (2010). Functions of T cells in asthma: More than just TH2 cells. Nature Reviews Immunology, 10(12), 838–848.
106. Lubbad, A., Oriowo, M., & Khan, I. (2009). Curcumin attenuates inflammation through inhibition of TLR-4 receptor in experimental colitis. Molecular and Cellular Biochemistry, 322(1–2), 127–135.
107. Luo, F., Song, X., Zhang, Y., & Chu, Y. (2011). Low-dose curcumin leads to the inhibition of tumor growth via enhancing CTL-mediated antitumor immunity. International Immunopharmacology, 11(9), 1234–1240.
108. Ma, C., Ma, Z., Fu, Q., & Ma, S. (2013). Curcumin attenuates allergic airway inflammation by regulation of CD4+ CD25+ regulatory T cells (Tregs)/Th17 balance in ovalbumin-sensitized mice. Fitoterapia, 87, 57–64.
109. Maheshwari, R. K., Singh, A. K., Gaddipati, J., & Srimal, R. C. (2006). Multiple biological activities of curcumin: A short review. Life Sciences, 78(18), 2081–2087.
110. Matasić, R., Dietz, A. B., & Vuk-Pavlović, S. (1999). Dexamethasone inhibits dendritic cell maturation by redirecting differentiation of a subset of cells. Journal of Leukocyte Biology, 66(6), 909–914.
111. Mathy, M., Sanchez, C., Priem, F., & Henrotin, Y. (2007). 196 Curcumin inhibits interleukin-6,-8, nitric oxide and prostaglandin e 2 synthesis by bovine chondrocytes. Osteoarthritis and Cartilage, 15, C115.
112. Mathy-Hartert, M., Jacquemond-Collet, I., Priem, F., Sanchez, C., Lambert, C., & Henrotin, Y. (2009). Curcumin inhibits pro-inflammatory mediators and metalloproteinase-3 production by chondrocytes. Inflammation Research, 58(12), 899–908.
113. Mimche, P. N., Thompson, E., Taramelli, D., & Vivas, L. (2012). Curcumin enhances non-opsonic phagocytosis of Plasmodium falciparum through up-regulation of CD36 surface expression on monocytes/macrophages. Journal of Antimicrobial Chemotherapy, 67(8), 1895–1904.
114. Mirzaei, H., Naseri, G., Rezaee, R., Mohammadi, M., Banikazemi, Z., Mirzaei, H. R., … Sahebkar, A. (2016). Curcumin: A new candidate for melanoma therapy? International Journal of Cancer, 139(8), 1683–1695.
115. Mohammadi, A., Sahebkar, A., Iranshahi, M., Amini, M., Khojasteh, R., Ghayour-Mobarhan, M., & Ferns, G. A. (2013). Effects of supplementation with curcuminoids on dyslipidemia in obese patients: A randomized crossover trial. Phytother Research, 27(3), 374–379.
116. Momtazi, A., & Sahebkar, A. (2016). Difluorinated curcumin: A promising curcumin analogue with improved anti-tumor activity and pharmacokinetic profile. Current Pharmaceutical Design, 22(28):4386–4397.
117. Momtazi, A. A., Derosa, G., Maffioli, P., Banach, M., & Sahebkar, A. (2016). Role of microRNAs in the therapeutic effects of curcumin in non-Cancer diseases. Molecular Diagnosis & Therapy, 20(4):335–345.
118. Momtazi, A. A., Shahabipour, F., Khatibi, S., Johnston, T. P., Pirro, M., & Sahebkar, A. (2016). Curcumin as a microRNA regulator in cancer: A review. Reviews of Physiology, Biochemistry and Pharmacology, 171:1–38.
119. Moohebati, M., Yazdandoust, S., Sahebkar, A., Mazidi, M., Sharghi-Shahri, Z., Ferns, G., & Ghayour-Mobarhan, M. (2014). Investigation of the effect of short-term supplementation with curcuminoids on circulating small dense low-density lipoprotein concentrations in obese dyslipidemic subjects: A randomized double-blind placebo-controlled cross-over trial. ARYA Atheroscler, 10(5), 280–286.
120. Na, L. X., Yan, B. L., Jiang, S., Cui, H. L., Li, Y., & Sun, C. H. (2014). Curcuminoids target decreasing serum adipocyte-fatty acid binding protein levels in their glucose-lowering effect in patients with type 2 diabetes. Biomedical and Environmental Sciences, 27(11), 902–906.
121. Nakajima, C., Uekusa, Y., Iwasaki, M., Yamaguchi, N., Mukai, T., Gao, P., … Fujiwara, H. (2001). A role of interferon-γ (IFN-γ) in tumor immunity t cells with the capacity to reject tumor cells are generated but fail to migrate to tumor sitesin IFN-γ-deficient mice. Cancer Research, 61(8), 3399–3405.
122. Nicolaou, F., Teodoridis, J. M., Park, H., Georgakis, A., Farokhzad, O. C., Böttinger, E. P., … Ferenczi, K. (2003). CD11c gene expression in hairy cell leukemia is dependent upon activation of the proto-oncogenes ras andjunD. Blood, 101(10), 4033–4041.
123. Okamoto, Y., Tanaka, M., Fukui, T., & Masuzawa, T. (2011). Inhibition of interleukin 17 production by curcumin in mice with collageninduced arthritis. Biomed Research, 22, 299–304.
124. Okazaki, Y., Han, Y., Kayahara, M., Watanabe, T., Arishige, H., & Kato, N. (2010). Consumption of curcumin elevates fecal immunoglobulin A, an index of intestinal immune function, in rats fed a high-fat diet. Journal of Nutritional Science and Vitaminology, 56(1), 68–71.
125. Okunieff, P., Xu, J., Hu, D., Liu, W., Zhang, L., Morrow, G., … Ding, I. (2006). Curcumin protects against radiation-induced acute and chronic cutaneous toxicity in mice and decreases mRNA expression of inflammatory and fibrogenic cytokines. International Journal of Radiation Oncology* Biology* Physics, 65(3), 890–898.
126. Pahl, H. L. (1999). Activators and target genes of Rel/NF-κB transcription factors. Oncogene, 18(49).
127. Pan, M.-H., Lin-Shiau, S.-Y., & Lin, J.-K. (2000). Comparative studies on the suppression of nitric oxide synthase by curcumin and its hydrogenated metabolites through down-regulation of IκB kinase and NFκB activation in macrophages. Biochemical Pharmacology, 60(11), 1665–1676.
128. Panahi, Y., Sahebkar, A., Amiri, M., Davoudi, S. M., Beiraghdar, F., Hoseininejad, S. L., & Kolivand, M. (2012). Improvement of sulphur mustard-induced chronic pruritus, quality of life and antioxidant status by curcumin: Results of a randomised, double-blind, placebo-controlled trial. The British Journal of Nutrition, 108(7):1272–1279.
129. Panahi, Y., Sahebkar, A., Parvin, S., & Saadat, A. (2012). A randomized controlled trial on the anti-inflammatory effects of curcumin in patients with chronic sulphur mustard-induced cutaneous complications. Annals of Clinical Biochemistry, 49(6), 580–588.
130. Panahi, Y., Khalili, N., Hosseini, M. S., Abbasinazari, M., & Sahebkar, A. (2014). Lipid-modifying effects of adjunctive therapy with curcuminoids-piperine combination in patients with metabolic syndrome: Results of a randomized controlled trial. Complementary Therapies in Medicine, 22(5), 851–857.
131. Panahi, Y., Rahimnia, A. R., Sharafi, M., Alishiri, G., Saburi, A., & Sahebkar, A. (2014). Curcuminoid treatment for knee osteoarthritis: A randomized Double-Blind Placebo-Controlled trial. Phytotherapy Research, 28(11), 1625–1631.
132. Panahi, Y., Saadat, A., Beiraghdar, F., & Sahebkar, A. (2014). Adjuvant therapy with bioavailability-boosted curcuminoids suppresses systemic inflammation and improves quality of life in patients with solid tumors: A randomized double-blind placebo-controlled trial. Phytotherapy Research, 28(10):1461–1467.
133. Panahi, Y., Badeli, R., Karami, G. R., & Sahebkar, A. (2015). Investigation of the efficacy of adjunctive therapy with bioavailability-boosted curcuminoids in major depressive disorder. Phytotherapy Research, 29(1):17–21.
134. Panahi, Y., Ghanei, M., Bashiri, S., Hajihashemi, A., & Sahebkar, A. (2015). Short-term curcuminoid supplementation for chronic pulmonary complications due to sulfur mustard intoxication: Positive results of a randomized double-blind placebo-controlled trial. Drug Research, 65(11):567–573.
135. Panahi, Y., Alishiri, G. H., Parvin, S., & Sahebkar, A. (2016). Mitigation of systemic oxidative stress by curcuminoids in osteoarthritis: Results of a randomized controlled trial. Journal of Dietary Supplements, 13(2):209–220.
136. Panahi, Y., Hosseini, M. S., Khalili, N., Naimi, E., Simental-Mendia, L. E., Majeed, M., & Sahebkar, A. (2016). Effects of curcumin on serum cytokine concentrations in subjects with metabolic syndrome: A post-hoc analysis of a randomized controlled trial. Biomedicine & pharmacotherapy, 82:578–582.
137. Panahi, Y., Khalili, N., Sahebi, E., Namazi, S., Karimian, M. S., Majeed, M., & Sahebkar, A. (2016). Antioxidant effects of curcuminoids in patients with type 2 diabetes mellitus: A randomized controlled trial. Inflammopharmacology, doi: 10.1007/s10787-016-0301-4
138. Panahi, Y., Kianpour, P., Mohtashami, R., Jafari, R., Simental-Mendia, L. E., & Sahebkar, A. (2016). Curcumin lowers serum lipids and uric acid in subjects with nonalcoholic fatty liver disease: A randomized controlled trial. Journal of cardiovascular pharmacology, 68(3):223–229.
139. Park, K.-R., Lee, J.-H., Choi, C., Liu, K.-H., Seog, D.-H., Kim, Y.-H., … Yea, S. S. (2007). Suppression of interleukin-2 gene expression by isoeugenol is mediated through down-regulation of NF-AT and NF-κB. International Immunopharmacology, 7(9), 1251–1258.
140. Park, M.-J., Moon, S.-J., Lee, S.-H., Yang, E.-J., Min, J.-K., Cho, S.-G., … Cho, M.-L. (2013). Curcumin attenuates acute graft-versus-host disease severity via in vivo regulations on Th1, Th17 and regulatory T cells. PLoS ONE, 8(6), e67171.
141. Radtke, F., Fasnacht, N., & MacDonald, H. R. (2010). Notch signaling in the immune system. Immunity, 32(1), 14–27.
142. Raflee, P., Nelson, V., Manley, S., Wellner, M., Floer, M., Binion, D., & Shaker, R. (2009). Effect of curcumin on acidic pH-induced expression of IL-6 and IL-8 in human esophageal epithelial cells (HET-1A): Role of PKC, MAPKs, and NF-ĸB. American Journal of Physiology - Gastrointestinal and Liver Physiology, 296, G388–G398.
143. Rahimnia, A.-R., Panahi, Y., Alishiri, G., Sharafi, M., & Sahebkar, A. (2015). Impact of supplementation with curcuminoids on systemic inflammation in patients with knee osteoarthritis: Findings from a randomized double-blind placebo-controlled trial. Drug Research, 65(10), 521–525.
144. Rahmani, S., Asgary, S., Askari, G., Keshvari, M., Hatamipour, M., Feizi, A., & Sahebkar, A. (2016). Treatment of non-alcoholic fatty liver disease with curcumin: A randomized placebo-controlled trial. Phytother Research, 30(9), 1540–1548.
145. Rangaraju, S., Chi, V., Pennington, M. W., & Chandy, K. G. (2009). Kv1. 3 potassium channels as a therapeutic target in multiple sclerosis. Expert Opinion on Therapeutic Targets, 13(8), 909–924.
146. Rogers, N., Kireta, S., & Coates, P. (2010). Curcumin induces maturation-arrested dendritic cells that expand regulatory T cells in vitro and in vivo. Clinical & Experimental Immunology, 162(3), 460–473.
147. Sahebkar, A. (2010). Molecular mechanisms for curcumin benefits against ischemic injury. Fertility and Sterility, 94(5), e75–6; author reply e77.
148. Sahebkar, A. (2013). Why it is necessary to translate curcumin into clinical practice for the prevention and treatment of metabolic syndrome? BioFactors, 39(2):197–208.
149. Sahebkar, A. (2014a). Are curcuminoids effective C-reactive protein-lowering agents in clinical practice? Evidence from a meta-analysis. Phytotherapy Research, 28(5), 633–642.
150. Sahebkar, A. (2014b). Curcuminoids for the management of hypertriglyceridaemia. Nature Reviews Cardiology, 11(2), 123.
151. Sahebkar, A. (2015). Dual effect of curcumin in preventing atherosclerosis: The potential role of pro-oxidant-antioxidant mechanisms. Natural Product Research, 29(6), 491–492.
152. Sahebkar, A., Cicero, A. F., Simental-Mendia, L. E., Aggarwal, B. B., & Gupta, S. C. (2016). Curcumin downregulates human tumor necrosis factor-alpha levels: A systematic review and meta-analysis ofrandomized controlled trials. Pharmacological Research, 107, 234–242.
153. Saito, S., Nakashima, A., Shima, T., & Ito, M. (2010). REVIEW ARTICLE: Th1/Th2/Th17 and regulatory T-Cell paradigm in pregnancy. American Journal of Reproductive Immunology, 63(6), 601–610.
154. Seroogy, C. M., & Gern, J. E. (2005). The role of T regulatory cells in asthma. Journal of Allergy and Clinical Immunology, 116(5), 996–999.
155. Seyedzadeh, M. H., Safari, Z., Zare, A., Gholizadeh Navashenaq, J., Razavi, S. A., Kardar, G. A., & Khorramizadeh, M. R. (2014). Study of curcumin immunomodulatory effects on reactive astrocyte cell function. International Immunopharmacology, 22(1), 230–235.
156. Shakibaei, M., Schulze-Tanzil, G., John, T., & Mobasheri, A. (2005). Curcumin protects human chondrocytes from IL-1β-induced inhibition of collagen type II and β1-integrin expression and activition of caspase-3: An immunomorphological study. Annals of Anatomy, 187(5-6), 487–497.
157. Shanmugam, N., Reddy, M. A., Guha, M., & Natarajan, R. (2003). High glucose-induced expression of proinflammatory cytokine and chemokine genes in monocytic cells. Diabetes, 52(5), 1256–1264.
158. Sharma, S., Chopra, K., Kulkarni, S., & Agrewala, J. (2007). Resveratrol and curcumin suppress immune response through CD28/CTLA-4 and CD80 co-stimulatory pathway. Clinical & Experimental Immunology, 147(1), 155–163.
159. Shirley, S. A., Montpetit, A. J., Lockey, R., & Mohapatra, S. S. (2008). Curcumin prevents human dendritic cell response to immune stimulants. Biochemical and Biophysical Research Communications, 374(3), 431–436.
160. Shishodia, S., Sethi, G., & Aggarwal, B. B. (2005). Curcumin: Getting back to the roots. Annals of the New York Academy of Sciences, 1056(1), 206–217.
161. Shishodia, S., Singh, T., & Chaturvedi, M. M. (2007). Modulation of transcription factors by curcumin, in The molecular targets and therapeutic uses of curcumin in health and disease (pp. 127–148). London: Springer.
162. Soetikno, V., Sari, F. R., Veeraveedu, P. T., Thandavarayan, R. A., Harima, M., Sukumaran, V., … Watanabe, K. (2011). Curcumin ameliorates macrophage infiltration by inhibiting NF-κB activation and proinflammatory cytokines in streptozotocin induced-diabetic nephropathy. Nutrition & metabolism, 8(1), 1.
163. Strimpakos, A. S., & Sharma, R. A. (2008). Curcumin: Preventive and therapeutic properties in laboratory studies and clinical trials. Antioxidants & Redox Signaling, 10(3), 511–546.
164. Sugimoto, K., Hanai, H., Tozawa, K., Aoshi, T., Uchijima, M., Nagata, T., & Koide, Y. (2002). Curcumin prevents and ameliorates trinitrobenzene sulfonic acid-induced colitis in mice. Gastroenterology, 123(6), 1912–1922.
165. Sun, L.-N., Yang, Z.-Y., Lv, S.-S., Liu, X.-C., Guan, G.-J., & Liu, G. (2014). Curcumin prevents diabetic nephropathy against inflammatory response via reversing caveolin-1 Tyr 14 phosphorylation influenced TLR4 activation. International Immunopharmacology, 23(1), 236–246.
166. Trocme, S. D., & Sra, K. K. (2002). Spectrum of ocular allergy. Current Opinion in Allergy and Clinical Immunology, 2(5), 423–427.
167. Tu, C.-T, Han, B., Yao, Q.-Y., Zhang, Y.-A., Liu, H.-C., & Zhang, S.-C. (2012). Curcumin attenuates Concanavalin A-induced liver injury in mice by inhibition of Toll-like receptor (TLR) 2, TLR4 and TLR9 expression. International Immunopharmacology, 12(1), 151–157.
168. Ukil, A., Maity, S., Karmakar, S., Datta, N., Vedasiromoni, J., & Das, P. K. (2003). Curcumin, the major component of food flavour turmeric, reduces mucosal injury in trinitrobenzene sulphonic acid-induced colitis. British Journal of Pharmacology, 139(2), 209–218.
169. Ung, V. Y., Foshaug, R. R., MacFarlane, S. M., Churchill, T. A., Doyle, J. S., Sydora, B. C., & Fedorak, R. N. (2010). Oral administration of curcumin emulsified in carboxymethyl cellulose has a potent anti-inflammatory effect in the IL-10 gene-deficient mouse model of IBD. Digestive Diseases and Sciences, 55(5), 1272–1277.
170. Varalakshmi, C., Ali, A. M., Pardhasaradhi, B. V. V., Srivastava, R. M., Singh, S., & Khar, A. (2008). Immunomodulatory effects of curcumin: In-vivo. International Immunopharmacology, 8(5), 688–700.
171. Varga, Z., Hajdu, P., & Panyi, G. (2010). Ion channels in T lymphocytes: An update on facts, mechanisms and therapeutic targeting in autoimmune diseases. Immunology Letters, 130(1), 19–25.
172. Wang, X. M., Kim, H. P., Nakahira, K., Ryter, S. W., & Choi, A. M. (2009). The heme oxygenase-1/carbon monoxide pathway suppresses TLR4 signaling by regulating the interaction of TLR4 with caveolin-1. The Journal of Immunology, 182(6), 3809–3818.
173. Wang, H.-M., Zhao, Y.-X., Zhang, S., Liu, G.-D., Kang, W.-Y., Tang, H.-D., … Chen, S.-D. (2010). PPARγ agonist curcumin reduces the amyloid-β-stimulated inflammatory responses in primary astrocytes. Journal of Alzheimer's Disease, 20(4), 1189–1199.
174. Wang, W., Kim, H. P., Nakahira, K., Ryter, S. W., & Choi, A. M. (2012). Enhanced bioavailability and efficiency of curcumin for the treatment of asthma by its formulation in solid lipid nanoparticles. International Journal of Nanomedicine, 7, 3667–3677.
175. Witte, T., Matthias, T., Arnett, F. C., Peter, H. H., Hartung, K., Sachse, C., … Lakomek, H. J. (2000). IgA and IgG autoantibodies against alpha-fodrin as markers for Sjogren's syndrome. Systemic lupus erythematosus. The Journal of Rheumatology, 27(11), 2617–2620.
176. Xiaoling, M., Jing, Z., Fang, X., Liangdan, T. (2010). Curcumin inhibits invasion and metastasis in the human ovarian cancer cells SKOV3 by CXCL12-CXCR4 axis. African Journal of Biotechnology, 9(48), 8230–8234.
177. Xie, L., Li, X.-K., Funeshima-Fuji, N., Kimura, H., Matsumoto, Y., Isaka, Y., & Takahara, S. (2009). Amelioration of experimental autoimmune encephalomyelitis by curcumin treatment through inhibition of IL-17 production. International Immunopharmacology, 9(5), 575–581.
178. Xie, L., Li, X.-K., & Takahara, S. (2011). Curcumin has bright prospects for the treatment of multiple sclerosis. International Immunopharmacology, 11(3), 323–330.
179. Xu, Y., Pindolia, K., Janakiraman, N., Noth, C., Chapman, R., & Gautam, S. (1997). Curcumin, a compound with anti-inflammatory and anti-oxidant properties, down-regulates chemokine expression in bone marrow stromal cells. Experimental Hematology, 25(5), 413–422.
180. Yadav, V., Mishra, K., Singh, D., Mehrotra, S., & Singh, V. (2005). Immunomodulatory effects of curcumin. Immunopharmacology and Immunotoxicology, 27(3), 485–497.
181. Yamaguchi, Y., Tsumura, H., Miwa, M., & Inaba, K. (1997). Contrasting effects of TGF-β1 and TNF-α on the development of dendritic cells from progenitors in mouse bone marrow. Stem Cells, 15(2), 144–153.
182. Youn, H. S., Saitoh, S. I., Miyake, K., & Hwang, D. H. (2006). Inhibition of homodimerization of Toll-like receptor 4 by curcumin. Biochemical Pharmacology, 72(1), 62–69.
183. Yu, W.-G., Xu, G., Ren, G.-J., Xu, X., Yuan, H.-Q., Qi, X.-L., & Tian, K.-L. (2011). Preventive action of curcumin in experimental acute pancreatitis in mouse. The Indian Journal of Medical Research, 134(5), 717.
184. Yun, J.-M., Jialal, I., & Devaraj, S. (2011). Epigenetic regulation of high glucose-induced proinflammatory cytokine production in monocytes by curcumin. The Journal of Nutritional Biochemistry, 22(5), 450–458.
185. Zabihi, N. A., Pirro, M., Johnston, T. P., & Sahebkar, A. (2016). Is there a role for curcumin supplementation in the treatment of non-alcoholic fatty liver disease? The data suggest yes. Current Pharmaceutical Design.
186. Zhang, L., Fiala, M., Cashman, J., Sayre, J., Espinosa, A., Mahanian, M., … Bernard, G. (2006). Curcuminoids enhance amyloid-β uptake by macrophages of Alzheimer's disease patients. Journal of Alzheimer's Disease, 10(1), 1–7.
187. Zhang, M., Deng, C., Zheng, J., Xia, J., & Sheng, D. (2006). Curcumin inhibits trinitrobenzene sulphonic acid-induced colitis in rats by activation of peroxisome proliferator-activated receptor gamma. International Immunopharmacology, 6(8), 1233–1242.
188. Zhang, M., Zheng, J., & Xia, J. (2006). Curcumin regulated shift from Th1 to Th2 in trinitrobenzene sulphonic acid-induced chronic colitis. Acta Pharmacologica Sinica, 27(8), 1071–1077.
189. Zhang, H.-G., Kim, H., Liu, C., Yu, S., Wang, J., Grizzle, W. E., … Barnes, S. (2007). Curcumin reverses breast tumor exosomes mediated immune suppression of NK cell tumor cytotoxicity. Biochimica et Biophysica Acta (BBA)-Molecular Cell Research, 1773(7), 1116–1123.